Evidence map›Paper›PMID 35633311›Full record

ArticleEpilepsia open2022

Impact of COVID-19 pandemic on epilepsy care in Japan: A national-level multicenter retrospective cohort study.

Naoto Kuroda, Takafumi Kubota, Toru Horinouchi, Naoki Ikegaya, Yu Kitazawa, Satoshi Kodama, Izumi Kuramochi, Teppei Matsubara, Naoto Nagino, Shuichiro Neshige and 57 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epilepsia open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

67 authors at 8 institutions in 3 countries.

Naoto KurodaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0003-1977-4893
Takafumi KubotaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0003-3632-9679
Toru HorinouchiJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Naoki IkegayaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Yu KitazawaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Satoshi KodamaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Izumi KuramochiJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0002-6416-5213
Teppei MatsubaraJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Naoto NaginoJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0002-0252-9990
Shuichiro NeshigeJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0002-5879-155X
Temma SogaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Yutaro TakayamaJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.
Daichi SoneJapan Young Epilepsy Section (YES-Japan), Tokyo, Japan.ORCID https://orcid.org/0000-0001-9617-706X
IMPACT-J EPILEPSY (In-depth Multicenter analysis during Pandemic of Covid19 Throughout Japan for Epilepsy practice) study group
Kousuke KanemotoNeuropsychiatric Department, Aichi Medical University, Aichi, Japan.
Akio IkedaDepartment of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0001-5368-0546
Kiyohito TeradaYokohama Minoru Epilepsy & Developmental Clinic, Kanagawa, Japan.
Hiroko GojiNeuropsychiatric Department, Aichi Medical University, Aichi, Japan.
Shinji OharaDepartment of Neurosurgery, Fukuoka Sanno Hospital, Fukuoka, Japan.
Koichi HagiwaraEpilepsy and Sleep Center, Fukuoka Sanno Hospital, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-3006-5692
Takashi KamadaEpilepsy and Sleep Center, Fukuoka Sanno Hospital, Fukuoka, Japan.
Koji IidaDepartment of Neurosurgery, Epilepsy Center, Hiroshima University, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Nobutsune IshikawaDepartment of Pediatrics, Epilepsy Center, Hiroshima University, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hideaki ShiraishiDepartment of Pediatrics, Hokkaido University Hospital, Epilepsy Center, Hokkaido, Japan.ORCID https://orcid.org/0000-0003-4199-0728
Osato IwataIwata Clinic, Tokyo, Japan.
Hidenori SuganoDepartment of Neurosurgery, Juntendo University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7836-6585
Yasushi IimuraDepartment of Neurosurgery, Juntendo University, Tokyo, Japan.
Takuichiro HigashiDepartment of Neurosurgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hiroshi HosoyamaDepartment of Neurosurgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Ryosuke HanayaDepartment of Neurosurgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan.ORCID https://orcid.org/0000-0002-4170-4878
Akihiro ShimotakeDepartment of Neurology, Kyoto University, Graduate School of Medicine, Kyoto, Japan.
Takayuki KikuchiDepartment of Neurosurgery, Kyoto University, Graduate School of Medicine, Kyoto, Japan.
Takeshi YoshidaDepartment of Pediatrics, Kyoto University, Graduate School of Medicine, Kyoto, Japan.
Hiroshi ShigetoDivision of Medical Technology, Department of Health Sciences, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan.
Jun YokoyamaNeurological Institute, Department of Neurology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan.
Takahiko MukainoNeurological Institute, Department of Neurology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-4091-5988
Masaaki KatoMusashino Kokubunji Clinic, Tokyo, Japan.
Masanori SekimotoMusashino Kokubunji Clinic, Tokyo, Japan.
Masahiro MizobuchiDepartment of Neurology, Nakamura Memorial Hospital, Hokkaido, Japan.
Yoko AburakawaDepartment of Neurology, Nakamura Memorial Hospital, Hokkaido, Japan.
Masaki IwasakiDepartment of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4204-7144
Eiji NakagawaDepartment of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Tomohiro IwataDepartment of Psychiatry, National Defense Medical College, Saitama, Japan.
Kentaro TokumotoEpilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
Takuji NishidaEpilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.ORCID https://orcid.org/0000-0001-5391-4656
Yukitoshi TakahashiEpilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
Kenjiro KikuchiDivision of Neurology, Children's Medical Center, Saitama, Saitama, Japan.
Ryuki MatsuuraDivision of Neurology, Children's Medical Center, Saitama, Saitama, Japan.ORCID https://orcid.org/0000-0002-4567-7678
Shin-Ichiro HamanoDivision of Neurology, Children's Medical Center, Saitama, Saitama, Japan.
Ayataka FujimotoComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
Hideo EnokiComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
Kyoichi TomotoDepartment of Neurosurgery, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
Masako WatanabeShinjuku Neuro Clinic, Tokyo, Japan.
Youji TakuboShinjuku Neuro Clinic, Tokyo, Japan.
Toshihiko FukuchiSuzukake Clinic, Aichi, Japan.
Hidetoshi NakamotoEpilepsy Center, TMG Asaka Medical Center, Saitama, Japan.
Yuichi KubotaEpilepsy Center, TMG Asaka Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-6487-2065
Naoto KuniiDepartment of Neurosurgery, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Yuichiro ShirotaDepartment of Clinical Laboratory Medicine, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Eiichi IshikawaDepartment of Neurosurgery, The University of Tsukuba, Faculty of Medicine, Ibaraki, Japan.
Nobukazu NakasatoDepartment of Epileptology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Taketoshi MaeharaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Motoki InajiDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Shunsuke TakagiDepartment of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Takashi EnokizonoDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
Yosuke MasudaDepartment of Neurosurgery, University of Tsukuba Hospital, Ibaraki, Japan.
Takahiro HayashiDepartment of Neurosurgery, Graduate School of Medicine, Yokohama City University, Kanagawa, Japan.
YKK (Japan) · JPHiroshima University · JPHokkaido University · JPMassachusetts General Hospital · USNational Center of Neurology and Psychiatry · JPTohoku University · JPUniversity Hospitals of Cleveland · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe impact of the coronavirus disease 2019 (COVID-19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study.

methodsThis study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy-center-specific monthly data divided by the 12-month average in 2019 for each facility. We determined whether the COVID-19 pandemic-related factors (such as year [2019 or 2020], COVID-19 cases in each prefecture in the previous month, and the state of emergency) were independently associated with these outcomes.

resultsIn 2020, the frequency of outpatient EEG studies (-10.7%, p<0.001) and cases with telemedicine (+2,608%, p=0.031) were affected. The number of COVID-19 cases was an independent associated factor for epilepsy admission (-3.75*10 SIGNIFICANCE: We demonstrated the significant impact that the COVID-19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic-related factor on epilepsy care.

Indexed as

epilepsy centerhospitalizationneurologyneurosurgerySARS-CoV-2

Identifiers

PMID35633311
PMCPMC9348370
OpenAlexW4281732801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.